tirzepatide 2.125 mg Mounjaro 12.5 Injection at ₹ 25000/vial | Tirzepatide Injection in Surat Mounjaro® (tirzepatide) — FDA-approved type

Administrar el medicamento: Presione y mantenga presionado el botn de inyeccin

doi:10.1172/JCI35414

Originally developed for type 2 diabetes management, tirzepatide gained FDA approval for weight loss under the brand name Zepbound in 2023 after clinical trials demonstrated superior weight loss compared to semaglutide and other GLP-1 medications

It is important to distinguish between medically indicated B12 injections prescribed for deficiency and lipotropic injections, which are typically unlicensed medicines in the UK and lack robust clinical evidence for weight loss

How is semaglutide administered

We tell patients to check with their insurance to see whats covered